Severe periodontitis and risk for poor glycemic control in patients with non‐insulin‐dependent diabetes mellitus
GW Taylor, BA Burt, MP Becker… - Journal of …, 1996 - Wiley Online Library
This study tested the hypothesis that severe periodontitis in persons with non‐insulin‐dependent
diabetes mellitus (NIDDM) increases the risk of poor glycemic control. Data from the …
diabetes mellitus (NIDDM) increases the risk of poor glycemic control. Data from the …
A longitudinal investigation of early reading and language skills in children with poor reading comprehension
K Nation, J Cocksey, JSH Taylor… - Journal of child …, 2010 - Wiley Online Library
Background: Poor comprehenders have difficulty comprehending connected text, despite
having age‐appropriate levels of reading accuracy and fluency. We used a longitudinal design …
having age‐appropriate levels of reading accuracy and fluency. We used a longitudinal design …
… CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor …
Imatinib-treated chronic myeloid leukemia (CML) patients with acquired resistance commonly
have detectable BCR-ABL kinase domain mutations. It is unclear whether patients who …
have detectable BCR-ABL kinase domain mutations. It is unclear whether patients who …
Poor predictive validity of the Bayley Scales of Infant Development for cognitive function of extremely low birth weight children at school age
M Hack, HG Taylor, D Drotar, M Schluchter… - …, 2005 - publications.aap.org
Objective. The Bayley Scales of Infant Development, Second Edition (BSID II) are commonly
used to assess outcomes of extremely low birth weight (ELBW) infants. We sought to assess …
used to assess outcomes of extremely low birth weight (ELBW) infants. We sought to assess …
Why research partnerships really matter: innovation theory, institutional arrangements and implications for developing new technology for the poor
A Hall, G Bockett, S Taylor, MVK Sivamohan, N Clark - World development, 2001 - Elsevier
This paper explores the conceptual basis for existing and emergent institutional patterns in
the context of partnership approaches to technology development. Drawing examples from …
the context of partnership approaches to technology development. Drawing examples from …
Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas
… Our current study provides support for the notion that the poor-prognosis OvCas can indeed
… also provide insights into their disproportionately poor prognosis relative to other types of …
… also provide insights into their disproportionately poor prognosis relative to other types of …
[PDF][PDF] KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan …
…, F Elliott, CL Daly, AM Meade, G Taylor… - Journal of Clinical …, 2009 - researchgate.net
Purpose Activating mutation of the KRAS oncogene is an established predictive biomarker
for resistance to anti–epidermal growth factor receptor (anti-EGFR) therapies in advanced …
for resistance to anti–epidermal growth factor receptor (anti-EGFR) therapies in advanced …
Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes
… Additionally, cognitive impairments have been linked by geriatricians to poor outcomes in …
, and its presence can identify patients at risk for poor outcomes, such as the development of …
, and its presence can identify patients at risk for poor outcomes, such as the development of …
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009)
Background During the first wave of pandemic H1N1 influenza in 2009, most cases outside
North America occurred in the UK. The clinical characteristics of UK patients hospitalised …
North America occurred in the UK. The clinical characteristics of UK patients hospitalised …
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up
… in the bone marrow correlate with poor prognosis and risk of … to MDS subgroup, increasing
with poor-risk disease. The … age is the best predictive model of a poor outcome,(P< 0.0001). …
with poor-risk disease. The … age is the best predictive model of a poor outcome,(P< 0.0001). …
